Neoleukin Therapeutics, Inc. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Neoleukin Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Neoleukin Therapeutics, Inc. for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.16 | 128,975 | 1,051,920 | 6,928,119 | 6.8 M to 6.9 M (+1.90 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.16 | 14,046 | 114,559 | 824,368 | 810.3 K to 824.4 K (+1.73 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 185,413 | 1,466,320 | 6,799,144 | 6.6 M to 6.8 M (+2.80 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 20,192 | 159,686 | 810,322 | 790.1 K to 810.3 K (+2.56 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.70 | 11,840 | 91,160 | 6,613,731 | 6.6 M to 6.6 M (+0.18 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.70 | 1,289 | 9,924 | 790,130 | 788.8 K to 790.1 K (+0.16 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.03 | 68,132 | 546,807 | 6,601,891 | 6.5 M to 6.6 M (+1.04 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.03 | 7,420 | 59,551 | 788,841 | 781.4 K to 788.8 K (+0.95 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.88 | 30,986 | 244,126 | 6,533,759 | 6.5 M to 6.5 M (+0.48 %) |
| Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.88 | 3,374 | 26,582 | 781,421 | 778 K to 781.4 K (+0.43 %) |
| Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | SHREWSBURY STEPHEN B | CMO; Senior VP Clin ... | Option Exercise | A | 8.08 | 35,000 | 282,800 | 35,000 | |
| Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | Mitchell David Chilton | VP Global Regulator ... | Option Exercise | A | 8.08 | 25,000 | 202,000 | 25,000 | |
| Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | Main David | President and CEO | Option Exercise | A | 8.08 | 120,000 | 969,600 | 120,000 | |
| Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Option Exercise | A | 8.08 | 35,000 | 282,800 | 35,000 | |
| Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Option Exercise | A | 8.08 | 40,000 | 323,200 | 40,000 |